With a robust clinical-stage pipeline, Agenus harnesses a mix of proprietary antibody platforms, like Retrocyte Exhibit™ and SECANT®, and revolutionary cell therapy techniques, positioning alone as a important contributor while in the biotechnology and immunotherapy arena.Our expenditure management organization generates asset-based expenses, th